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learned by the RIMARC algorithm can be used for accurately 
classifying the preoperative rhythm status. APs were included 
from 221 SR and 158 AF patients. During a learning phase, 
the RIMARC algorithm established a ranking order of 62 fea-
tures by predictive value for SR or AF. The model was then 
challenged with an additional test set of features from 28 
patients in whom rhythm status was blinded. The accuracy of 
the risk prediction for AF by the model was very good (0.93) 
when all features were used. Without the seven AP features, 
accuracy still reached 0.71. In conclusion, we have shown 
that training the machine-learning algorithm RIMARC with 
an experimental and clinical data set allows predicting a clas-
sification in a test data set with high accuracy. In a clinical 
setting, this approach may prove useful for finding hypothe-
sis-generating associations between different parameters.
Abstract Ex vivo recorded action potentials (APs) in 
human right atrial tissue from patients in sinus rhythm (SR) 
or atrial fibrillation (AF) display a characteristic spike-and-
dome or triangular shape, respectively, but variability is huge 
within each rhythm group. The aim of our study was to apply 
the machine-learning algorithm ranking instances by maxi-
mizing the area under the ROC curve (RIMARC) to a large 
data set of 480 APs combined with retrospectively collected 
general clinical parameters and to test whether the rules 
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Abbreviations
AF  Atrial fibrillation
APA  Action potential amplitude (mV)
APD20  Action potential duration at 20 % of repolari-
zation (ms)
APD50  Action potential duration at 50 % of repolari-
zation (ms)
APD90  Action potential duration at 90 % of repolari-
zation (ms)
dV/dtmax  Maximum rate of depolarization (Vs
−1)
MAD  Maximum area under ROC curve-based 
discretization
PLT20  “Plateau potential” defined as the mean poten-
tial (mV) in the time window between 20 % of 
APD90 plus 5 ms
RIMARC  Ranking instances by maximizing the area 
under the ROC curve
RMP  Resting membrane potential (mV)
ROC  Receiver operating characteristics
SR  Sinus rhythm
1 Introduction
During open-heart surgery, the outer rim of the right atrial 
appendage is removed in order to introduce the tubing for 
connecting the patient to the extracorporeal circulation. 
Most patients agree that these tissue samples are made 
available for basic research rather than being disposed. 
Therefore, right atrial tissue can be studied ex vivo for its 
basic electrophysiological properties.
Action potentials (APs) recorded in right atrial tissue from 
patients in sinus rhythm (SR) exhibit a characteristic spike-
and-dome morphology that changes into a triangular form 
due to electrical remodeling in chronic atrial fibrillation (AF) 
[4, 19, 22]. Many studies have reported in silico modeling 
of atrial repolarization in order to understand the complex 
processes which underlie AF-induced changes [6, 7, 15]. 
Despite the clear association of AP shape with the patient’s 
preoperative rhythm status, the variability in individual AP 
morphology is large and does not always allow a clear dis-
tinction between SR and AF. Besides preoperative rhythm 
status, other demographic and clinical factors could have an 
influence on AP shape. Therefore, most published experimen-
tal studies with human atrial tissue also include additional 
information on the patients’ age, height, body weight, con-
comitant diseases, basal hemodynamic parameters, pre-surgi-
cal medication, etc. (e.g., [5, 23, 24] ). However, cohort sizes 
are usually quite small (<50 patients) so that weak influences 
of accompanying clinical conditions cannot be ruled out.
In the context of our electrophysiological interest in AF 
pathophysiology, we have accumulated a large data pool 
of human right atrial action potential recordings during the 
past 8 years. From all patients, we have also collected clini-
cal parameters from the electronic (scanned) patient files. 
Instead of using conventional statistics to find associations 
between AF and electrophysiological and clinical features, 
we used a machine-learning approach for risk prediction. 
In this context, the term “risk prediction” is used in a math-
ematical sense of correct classification and is not related to 
the clinical prediction of risk of getting a disease based on 
empirically observed risk factors for that disease.
The general objective of all machine-learning 
approaches can be stated as non-trivial extraction of previ-
ously unknown, however, hypothesis-generating premises, 
rules and relations from large data sets. Aligned with this 
particular objective, our study incorporated a machine-
learning algorithm ranking instances by maximizing the 
area under the ROC curve (RIMARC) [10] instead of a 
multivariate statistical approach.
The RIMARC algorithm was applied to a large data 
set of ex vivo recorded human right atrial APs combined 
with retrospectively collected general clinical parameters. 
Therefore, the aim of our study was to test whether the 
rules learned by this algorithm could be used for an accu-
rate classification of a patient’s rhythm status.
2  Methods
Data included in this study were collected in the period 
from January 2006 to February 2014. The study conforms 
to the Declaration of Helsinki and was approved by the eth-
ics committee of Dresden University of Technology (No. 
EK790799). Each patient gave written informed consent. 
Right atrial appendages were obtained from 221 patients with 
SR and 158 patients with chronic AF at the time of open-heart 
surgery. The criteria for a patient to be considered in perma-
nent AF were history of ECG-documented AF and symptoms 
of AF for ≥6 months. Patients with paroxysmal or intermit-
tent AF were excluded. Demographic and clinical data of the 
patients are summarized in Table 1 and are comparable to the 
characteristics published previously [6, 7, 15]. The Mann–
Whitney U test was applied for a complete statistical analysis 
of all features between the SR and AF group of patients, the 
results are provided in supplementary Table 1.
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2.1  Action potential measurements
Small pieces of human right atrial appendages were trans-
ported to the laboratory in a special Ca2+-free transport 
solution at 20–25 °C, composition in mM: 100.0 NaCl, 10.0 
KCl, 1,2 KH2PO4, 5.0 MgSO4, taurin 50 mM, MOPS 5 mM, 
30 mM butanedionemonoxime (BDM), pH 7.0 (20–25 °C). 
Either free-running trabeculae or trabeculae together with 
attached atrial wall were dissected and mounted on the bot-
tom of a 5-ml organ bath perfused with 50 ml of recircu-
lating, oxygenized Tyrode’s solution at a flow rate of 7 ml/
min at 36 ± 1 °C (composition in mM: 126.7 NaCl, 0.42 
NaH2PO4, 22 NaHCO3, 5.4 KCl, 1.8 CaCl2, 1.5 MgCl2, 
pH 7.4 when equilibrated with 5 % CO2 in O2). Prepara-
tions were electrically stimulated at a single constant rate 
of 1 Hz with isolated square-wave stimuli of 1 ms duration, 
two times threshold intensity. Transmembrane potentials 
were recorded with glass microelectrodes filled with 2.5 M 
KCl. Tip resistances of the electrodes were between 20 and 
80 MΩ. Both timing of the driving stimuli and preprocess-
ing of the transmembrane potential responses were carried 
out with a computer-aided AP recording system.
The trabeculae were used for various different experi-
ments; however, each experiment was preceded by a 
60-min equilibration period during which the preparations 
were allowed to stabilize and residual BDM was com-
pletely washed out. At the end of the equilibration period, 
10 consecutive APs were averaged and analysed for the 
following parameters (Fig. 1): resting membrane poten-
tial, RMP (mV), action potential amplitude, APA (mV), 
action potential duration at 20, 50, and 90 % of repolariza-
tion (APD20, APD50 and APD90 in ms), maximum rate of 
depolarization, dV/dtmax (V/s), and the “plateau potential” 
(PLT20) defined as the mean absolute membrane potential 
(mV) in a 5-ms window starting from 20 % of APD90.
The clinical parameters chosen for our data set are demo-
graphic characteristics such as age, weight, body mass index 
(BMI), etc., clinical conditions associated with heart disease, 
hemodynamic parameters, and medication. Routine methods 
and clinical laboratory tests were used for assessment of clini-
cal parameters. For example, left atrial or left ventricular end-
diastolic diameter, right ventricular systolic pressure, left ven-
tricular end-diastolic pressure, left ventricular end-diastolic 
diameter, ejection fraction, cardiomyopathy, left ventricular 
posterior wall thickness, interventricular septum thickness, 
mitral or aortic valve insufficiency, aortic stenosis, and patent 
foramen ovale were determined with trans-thoracal or trans-
esophageal echocardiography. Right heart catheterization was 
required for diagnosis of pulmonary hypertension and some-
times for measuring right ventricular systolic pressure. Right 
coronary artery stenosis and number of occluded vessels were 
diagnosed by coronary angiography. Chronic pulmonary 
obstructive disease (CPOD) was quantified with spiro-ergo-
metric methods. The complete list of all electrophysiological 
and clinical parameters is given in Table 2.
2.2  Data set
All patients who agreed to participate in this study were 
anonymized, but had to be assigned a consecutive code 
Table 1  Patient characteristics
SR sinus rhythm, cAF chronic atrial fibrillation (≥6 months), m male, 
f female; LVEF left ventricular ejection fraction, LVEDP left ven-
tricular end-diastolic pressure, LAD left atrial diameter, LVEDD left 
ventricular end-diastolic diameter, IVS interventricular septum, LVPW 
left ventricular posterior wall, ACE angiotensin-converting enzyme, 
AT1 angiotensin- type 1 receptor, β-blockers, β-adrenoceptor blockers
**** P < 0.0001, AF versus SR from Student’s two-tailed, unpaired t test
† Mann–Whitney U test, null-hypothesis rejected (with significance 
0.001 and confidence interval 95 %)
a Values in square brackets indicate number of patients for which val-
ues are available
b The categories “yes,” “no,” and “no information” apply to the 
remaining 11 features
SR cAF
Patients, n 221 158
Gender, m/f (m %) 156/65 (70.6 %) 94/64 (59.1 %)
Age (years) 67.8 ± 0.68 72.9 ± 0.57****
Height (m) 1.70 ± 0.01 1.69 ± 0.01
Weight (kg) 79.5 ± 0.91 79.8 ± 1.15
Body mass index (kg/m2) 27.4 ± 0.25 27.6 ± 0.37
LVEF (%) [n patients]a 54.6 ± 0.92 [194]a 52.6 ± 0.92 [156]
LVEDP (mm Hg) [n 
patients]
17.0 ± 0.92 [76] 16.0 ± 0.69 [81]
LAD (mm) [n patients] 42.2 ± 0.43 [156] 51.3 ± 0.66 [145]****
LVEDD (mm) [n patients] 49.9 ± 0.62 [156] 51.2 ± 0.67 [134]
IVS (mm) [n patients] 12.8 ± 0.18 [150] 12.9 ± 0.16 [132]
LVPW (mm) [n patients] 12.2 ± 0.17 [146] 12.4 ± 0.16 [131]
Bypass, n (%) 141 (55.1 %) 24 (10.7 %)†
Valve replacement (n) 71 (27.7 %) 155 (69.2 %)†
Bypass plus valve replace-
ment (n)
44 (17.2 %) 44 (19.6 %)
Other surgery 0 1 (0.4 %)
Hypertension, n (yes, no, 
no inform.)b
180, 14, 27 150, 5, 3
Diabetes (n) 80, 140, 1 64, 94, 0
Hyperlipidemia (n) 151, 43, 27 108, 46, 4
Digitalis (n) 6, 188, 28 57, 92, 4†
ACE inhibitors (n) 131, 64, 26 93, 57, 8
AT1 blockers (n) 40, 153, 28 45, 103, 10
β-Blockers (n) 170, 25, 25 132, 21, 5
Dihydropyridines (n) 36, 157, 28 35, 114, 9
Diuretics (n) 90, 103, 28 104, 45, 9†
Nitrates (n) 31, 162, 28 19, 130, 9
Lipid-lowering drugs (n) 132, 61, 28 81, 68, 9
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number known only to the project leader. This number was 
used to identify the medical file for collection of available 
clinical parameters. Patients for whom no clinical data was 
available were eliminated.
The data set comprised of a total of 480 instances from 
379 patients (instances): 452 instances from 351 patients 
were used for training the algorithm and 28 instances from 
28 patients were used for testing. The latter instances were 
assigned to the testing group, because they were collected 
after an arbitrary deadline we set for the learning group. 
In the training data set, there were 214 AF and 238 SR 
instances, and in the test data set, there were 10 AF and 18 
SR instances, and for some patients, action potentials were 
measured in more than one experiment and were therefore 
treated as separate instances. This is an accepted approach 
in machine learning.
All instances are labeled as AF (positive, “P”) or SR 
(negative, “N”). A total of 62 features (seven AP parame-
ters and 56 clinical parameters) were used. Of the features, 
24 were numerical (continuous) and 38 were categorical. 
In both groups, some clinical parameters were missing; the 
percentage of missing values was 27 % for the training and 
2 % for the test data set.
2.3  Calculations
2.3.1  Training phase
As a machine-learning algorithm, RIMARC is used to 
distinguish the features and their particular values (or 
value ranges) that are indicators of AF. This algorithm has 
been designed to maximize the area under the ROC curve 
(AUC). It learns a ranking function, which is a linear com-
bination of nonlinear scoring functions and is learned for 
each feature. The RIMARC algorithm first discretizes each 
continuous feature using a maximum area under ROC 
curve-based discretization (MAD2C) algorithm [17]. For 
example, the numerical feature APD90 is converted into a 
categorical feature by partitioning the range of all values, 
e.g., 140–467 ms, into sub-ranges, e.g., 140–192.5, 192.5–
205.5, 205.5–229.5, 229.5–243.5, 243.5–247.5 ms, and so 
on. Thus, each numerical feature is converted into a cate-
gorical one by assigning a label to each of these sub-ranges. 
All values of a numerical feature, e.g., APD90, are replaced 
by labels corresponding to the sub-ranges in the data set. 
For example, an APD90 value of 234 ms will be replaced by 
the label “229.5. 243.5.” It is shown that probability can be 
used as scoring function for achieving the maximum AUC 
for a single categorical feature [10]. In this context, prob-
ability is the ratio of number of AF cases divided by the 
number of all cases in corresponding categorical value in 
the training data set. For example, the score associated with 
the label “229.5.243.5” is 0.8928 [=25/(25 + 3)], since 
there are 25 AF and three SR cases.
For each feature, the instances in the data set are sorted 
by the corresponding scoring function (probability). The 
ROC curve (Fig. 2) is constructed, labeling the AF patients 
as “P” and SR patients as “N” and calculating true positive 
rate (TRP) and false positive rate (FPR) of the instances 
within the class labels (ranges of values) obtained by the 
discretizing process to yield the maximum area under 
the curve. The data set is sorted in the order of the score 
assigned to the ranges of values, and TPR and FPR are 
calculated in a cumulative manner by working through the 
sorted list of instances one by one. Mathematically, TPR is 
the number of true positive instances divided by number of 
all instances marked as positive, and FPR is the number of 
false positive instances divided by number of all negative 
instances in the data set. The area under the ROC curve 
(AUC) is an indicator of the quality of the ranking; the 
higher the AUC value, the better the ranking is.
The discretization with MAD2C algorithm [23] opti-
mizes the AUC. Figure 2 illustrates ROC curves for the 
feature APD90, as a continuous feature (Fig. 2a) and as a 
discretized feature (Fig. 2b). Without any discretization, 
the AUC is 0.950, and after the discretization, it slightly 
increases to 0.957. This increment in the value of AUC is 
attributed to the objective function of MAD2C algorithm 
that aims to yield the maximum AUC by discretizing the 
continuous range of a feature into optimal discrete ranges.
The AUC value can be used to compute the predictive 
weight of a feature to classify a patient as AF or SR. The 
RIMARC algorithm computes the weight of a feature f as 
wf = 2(AUC(f) − 0.5), where AUC(f) is the AUC obtained 
for the feature f. If the AUC is equal to 1, classification is 
Fig. 1  Action potential from a patient in sinus rhythm to illustrate 
analysis of action potential parameters. APA action potential ampli-
tude (mV); RMP resting potential (mV), APD20, APD50, and APD90, 
action potential duration at 20, 50, and 90 % of repolarization (in 
ms), dV/dtmax, maximum rate of depolarization (Vs
−1), and the “pla-
teau potential” defined as the mean absolute membrane potential 
(mV) in the time window between 20 % of APD90 plus 5 ms (PLT20)
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Table 2  List of features ordered according to predictive weight
Feature name Predictive weight Feature name Predictive weight
APD90 (ms) 0.9135 dV/dtmax (V/s) 0.1976
APD20 (ms) 0.8622 Aortic valve insufficiency 0.1936
Left atrial end-diastolic diameter (mm) 0.7513 Body mass index 0.1783
APD50 (ms) 0.7475 Patent foramen ovale 0.1691
PLT20 (mV) 0.6157 Left ventricular ejection fraction (%) 0.1616
APA (mV) 0.5451 Aortic valve insufficiency Grade I-II 0.1545
Pulmonary hypertension 0.5309 Left ventricle end-diastolic diameter (mm) 0.1513
Surgical procedure 0.4943 Intraventricular septum thickness at diastole (mm) 0.1338
QT-time (ms) 0.4515 Aortic Stenosis 0.1244
RMP (mV) 0.4272 Left ventricular wall thickness at diastole (mm) 0.1205
Number of occluded vessels 0.4181 Weight (kg) 0.1163
Creatinine 0.4106 Lipid-lowering drugs 0.1100
Glomerular filtration rate (GFR) 0.4104 Sex 0.1082
Right ventricular systolic pressure 35–54 mmHg 0.4061 Nicotine 0.1035
Mitral valve insufficiency Grade III 0.4031 AT1 blocker 0.0889
Mitral valve insufficiency 0.3693 Left ventricular hypertrophy 0.0824
QTc-time (ms) 0.3585 Hyperlipidemia 0.0639
Diuretic 0.3459 Hypertension 0.0625
Digitalis 0.3458 Mitral stenosis Grade II–III 0.0598
Age (years) 0.3411 Aortic valve insufficiency Grade III 0.0566
Right coronary artery stenosis >70 % 0.3395 Calcium channel blocker 0.0563
Potassium, serum (mmol/l) 0.3337 Nitrate 0.0494
Anamnestic or actual decompensation 0.3245 Mitral valve insufficiency Grade II 0.0386
Mitral valve insufficiency Grade I 0.3228 Aortic stenosis Grade I–II 0.0354
Tricuspid valve insufficiency Grade II–III 0.3072 Inflammatory process 0.0243
Aortic stenosis Grade III 0.2222 Chronic obstructive pulmonary disease 0.0213
Left ventricular end-diastolic pressure (mmHg) 0.2140 Obstructive sleep apnea syndrome 0.0203
Heart failure NYHA III 0.2125 ACE Inhibitor 0.0193
Height (m) 0.2038 Betablocker 0.0122
Myocardial infarction 0.1984 Diabetes 0.0059
Right ventricular systolic pressure >55 mmHg 0.1976 Cardiomyopathy 0.0047
Fig. 2  ROC curves for the 
feature APD90, as a continuous 
feature (a) and as a discre-
tized feature (b). Without any 
discretization, the area under 
the ROC curve (AUC) is 0.950 
(95 % CI, 0.930–0.971) with the 
standard error of 0.011 under 
the nonparametric assumption. 
However, after the discretization 
with MAD2C algorithm [23], 
AUC for APD90 (b) increases 
slightly and becomes 0.957 
(95 % CI, 0.938–0.975) with the 
standard error of 0.009 under 
the nonparametric assumption
ROC Curve of APD90
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perfect, whereas a value of 0.5 indicates that random guess-
ing has occurred [17].
The training phase is completed by forming one rule 
for each feature. A rule for a feature contains a score cor-
responding to each possible value of that feature and the 
predictive weight for that feature.
2.3.2  Classification phase
The rule model learned by the RIMARC algorithm can be 
used for predicting whether a patient belongs to the AF 
class (risk score). The risk score of AF for a given query 
patient q is given by the following formula:
Here, wf represents the weight of the feature f, qf is its 
value, and sf(q) is the score associated with the value of 
feature f for the query patient q. For coping with missing 
values when computing the risk score, the RIMARC algo-
rithm ignores a feature if the query patient has no value for 
that feature. As shown in the formula above, wf
q is zero, if 
the value of feature f is missing in patient q; otherwise, it is 
the weight of feature f.
All training instances are sorted by the risk score func-
tion given above (1). Let nN be the number of negative (SR) 
patients in the training data set, and let us define a cutoff 
score as
Here, score(tnN) represents the score of the nN
th training 
instance. If the risk score function is perfect, all first nN 
training instances will be negative instances. Vice versa, all 
instances whose risk score value is greater than c must be 
positive instances (see Fig. 3). Thus, we predict the class of 
a query patient as P if its risk score is greater than c; nega-
tive otherwise.
3  Results
3.1  Electrophysiological recordings
In our large cohort of human right atrial APs, we confirm 
the characteristic spike-and-dome (SR) and a more trian-
gular conformation (AF) (Fig. 4). With the exception of 















wf qf is known




P if score(q) > c
N otherwise
where c =
scors(tnN ) + scors(tnN+1)
2
commonly analysed AP parameters (i.e., APD90, APD50, 
APD20, PLT20, APA, RMP) were highly significantly dif-
ferent among SR and AF groups. The histograms in Fig. 5 
show substantial overlap of value distribution.
3.2  Rules generated by the RIMARC algorithm
All electrophysiological and clinical features according to 
their predictive weights calculated by the RIMARC algo-
rithm are listed in decreasing order of predictive power in 
Table 2. The rules for all features are given in Supplemen-
tary Table 2. Using the MAD2C algorithm, RIMARC auto-
matically divided the total range of the feature APD90 into 
11 sub-ranges. For the rule about the feature APD90, our 
training data set contained 71 instances of APD90 values in 
the range of 205.5 and 229.5 ms, and 91.5 % were from 
patients with AF. The risk plot depicted in Fig. 6 demon-
strates the nonlinear increase in risk with decreasing values 
of APD90. Further, the predictive weight of APD90 is 0.9135 
which is the highest among all the features.
Left atrial diastolic diameter was divided into 10 sub-
ranges. According to this particular rule learned from the 
training data, all 44 cases, i.e., 100 %, with left atrial diam-
eter larger than 55.5 mm, and 90.9 % of the cases with left 
atrial diameters in the range of 52.5–55.5 mm had AF. The 
predictive weight of this feature was 0.7513.
All patients required cardiac surgery, including valve 
replacement only, valve replacement plus closure of atrial 
septal defect (ASD), valve replacement plus coronary 
artery bypass, and coronary artery bypass only. According 
to the rule about surgical procedure, there were 215 cases 























Fig. 3  Illustration to calculate the cutoff score c in a toy data set. All 
instances are sorted by their individual risk score given by Eq. (1). N 
(negative instances) represent SR patients; P (positive instances) rep-
resent AF patients, nN is the total number of negative instances, e.g., 
nN = 6 in this data set; cutoff score c is calculated by Eq. (2), i.e., 
average between risk score of instances six and seven from the top. 
See text for further details
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weight is 0.4943 making it the eighth most effective feature 
for AF classification.
According to the rule about diabetes, 47 % of the 170 
cases with diabetes in the training data set had AF. On 
the other hand, the same percentage of 281 cases without 
diabetes had AF, as well. The predictive weight of diabetes 
is 0.0059, which is second to the least predictive feature.
The rule learned for age discretizes the total age range 
into nine sub-ranges. For the sub-range 65.5–67.5 years, 
50 % of the 40 cases in the training data set had AF. The 
Fig. 4  a Characteristic traces 
of two human right atrial action 
potentials representative for 
tissue from a sinus rhythm 
(SR) and an atrial fibrilla-
tion (AF) patient. b Mean 
values ± standard error of the 
mean, n number of patients; σSR 
and σAF, standard deviation for 
SR and AF, respectively. See 
legend of Fig. 1 for explanation 
of abbreviations
SR (n = 238) 
[CI = 0.999] σ SR
AF (n = 214)
[CI = 0.999] σ AF
Sig (2-tailed) 
[CI = 0.999] 
APD90 ms 317.41  9.33 43.19 217.45  8.15 35.74 < 0.001
APD50 ms 138.09  9.75 45.14 100.41  6.31 27.68 < 0.001
APD20 ms 7.22  1.83 8.48 29.41  4.15 18.17 < 0.001
PLT20 mV  -16.28  1.40 6.49 -5.09  2.57  11.26 < 0.001
APA mV 94.95  1.52  7.07 101.56  1.76 7.71 < 0.001
RMP mV  -73.98  0.86  3.99  -76.85  0.83  3.61 < 0.001




























































Fig. 5  Histograms of selected action potential parameters from SR 
(black columns) and AF trabeculae (red columns): APD20, APD90, 
PLT20, APA, RMP, dV/dtmax. Ordinate: number of preparations with 
the ranges indicated by the bins (abscissa). Please note the huge vari-
ability within the SR and AF groups
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predictive weight of age is computed to be 0.3411. The rule 
demonstrates that the probability of AF increases monoton-
ically as the age increases (see also risk plot in Fig. 6).
3.3  Testing phase
In order to validate the rules learned by the RIMARC 
algorithm, we reserved data from a separate group of 28 
patients. The risk scores for these patients are computed 
according to Eq. 1 which is based on the rules learned 
in the training phase. The rhythm values for 28 test 
instances are predicted by Eq. 2. At the end of the train-
ing phase, the cutoff score was found to be 0.548. Those 
instances with risk score greater than 0.548 are predicted 
to be AF.
Two out of 28 test instances were misclassified, i.e., one 
SR patient was predicted to belong to the AF group, and 
one AF patient was predicted to belong to the SR group. 
In fact, the shapes of the APs recorded in these two mis-
classified patients (see Fig. 7) were not typical for their 
respective rhythm group. The classification accuracy was 
0.93 (26/28) when all features were used. The increase in 
accuracy with increasing numbers of features in the order 
of their predictive weight (predictive weight or “risk value” 
in Table 2) is illustrated in Fig. 8. In fact, the six features 
with the highest weight, i.e., APD90, APD20, Left atrial 
diastolic diameter, APD50, PLT20, and APA, were enough to 
obtain 0.93 classification accuracy. Excluding all seven AP 
features from the training data set, classification accuracy 





















































Fig. 6  Plots of risk scores generated from the rules learned by RIMARC for APD90, left atrial diameter, age, and pulmonary hypertension. The 
risk score is the probability of a patient within the discretized sub-ranges to belong to the AF group
100 ms
-50 mV




   0 mV
21.08.2013
Pat. 3850 (SR)Pat. 3832 (AF) 
Fig. 7  Action potentials from the two patients (3,832, 3,850) misclassified in the test data set. According to the clinical records, patient 3,832 
had been in AF but was classified as SR, and patient 3,850 had been in SR but was classified as AF
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4  Discussion
In the present study, we have used a large ex vivo electro-
physiological data set from human atrial biopsies as well 
as clinical information for training a machine-learning 
algorithm to establish a ranking order of features by pre-
dictive value for preoperative AF. The major findings were 
(i) APD90, APD20, and left atrial diastolic diameter had 
the highest predictive values; (ii) pulmonary hypertension 
ranked on place seven for predictive weight, (iii) the clini-
cal features “diabetes” and “treatment with β-blockers” had 
lowest predictive values, and (iv) challenging the model 
with a test data set yielded high accuracy in risk prediction.
4.1  Action potentials
In chronic AF, the APD is significantly shorter than in SR 
due to electrical remodeling [4, 25], although there is a 
substantial overlap in value distributions between the two 
groups (see Fig. 5). The variability in AP morphology, 
regardless of rhythm status, confirms reports in the litera-
ture [1–3, 9, 13, 19, 21, 24]. Despite this variability, APD90 
and APD20 have the highest predictive values in our model. 
Based on our results, the plateau potential PLT20 has more 
negative values in SR than in AF; its predictive weight is 
0.6157 for a patient to be in AF.
4.2  Clinical features
Atrial fibrillation is characterized by highly irregular excit-
atory activity that can be triggered by ectopic pacemakers 
often located in the left atrium and the pulmonary veins 
[11]. Dilation of the left atrium enhances the likelihood 
of ectopic activity and stability of re-entrant circuits, and 
hence susceptibility to AF [8, 16], providing a pathophysi-
ological link between mitral valve stenosis or congestive 
heart failure and increased risk of AF. Thus, the high pre-
dictive weight of the feature left atrial diameter in our data 
set was not surprising. Pulmonary hypertension, however, 
is not among the well-established risk factors for AF [20], 
yet its predictive weight (0.5309) ranked on position seven 
among the 62 predictive features in our data set. In the gen-
eral population, old age is associated with an increase in 
pulmonary artery pressure [18], and an expert panel on pul-
monary hypertension has recently suggested to introduce a 
new clinical entity of “pulmonary hypertension of old age” 
(Ali Oto, personal communication). Age is also a known 
risk factor for AF (for review see [14] ). In our data set, 
the rule for age provided by the RIMARC algorithm dem-
onstrates continuously increasing risk score for AF with 
increasing age, suggesting that there might be an associa-
tion between pulmonary hypertension and AF, illustrating 
the hypothesis-generating aspect of our approach.
On the other hand, age had a rather low predictive 
weight for AF in our data set, despite the fact that old age is 
an accepted risk factor for AF [14]. This seeming discrep-
ancy is possibly due to the particular set of patients stud-
ied, because patients were not primarily selected for heart 
rhythm, but, for obvious reasons, only patients requiring 
open-heart surgery could be included. Similarly, patient 
selection may also explain the low predictive weight of 
diabetes and drug treatment, because these two features are 
similar in all severely ill cardiac patients.
4.3  Machine-learning algorithm
The RIMARC algorithm is chosen to be applied in our 
study due to its several prominent characteristics. First of 
all, RIMARC achieves comparably high AUC (Area Under 
the ROC Curve) values, which is the ultimate measure of 
the precision of a classifier. There are benefits to using such 
a measure, since AUC has important characteristics, such 
as insensitivity to class distribution and cost distributions. 
Another benefit of the AUC is that it has an intuitive prob-
ability interpretation: The AUC represents the probabil-
ity that a randomly chosen positive instance is correctly 
assigned a higher rank value than a randomly selected 
negative instance. Therefore, the weights of the features are 
proportional to their ability to independently classify the 
instances. Since the RIMARC algorithm uses all available 
feature values and ignores the missing ones, it is robust to 
missing feature values. For this reason, it is ideally situated 
as a valid machine-learning method with experimental and 
clinical data sets comprising substantial amount of missing 
values due to the difficulties in data collection and consoli-
dation. In addition to this, being a nonparametric method, 
RIMARC does not require tuning of any parameters to 
Fig. 8  Accuracy of rhythm classification in the test data set with 
increasing numbers of features used for the training phase (top 10 
features of Table 1, i.e., APD90, APD20, Left atrial diastolic diameter, 
APD50, PLT20, APA, pulmonary hypertension, surgical procedure, 
QT-time, and RMP. Please note that the top six features with the 
highest predictive weight provided total accuracy
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achieve the best performance. Nonparametric methods are 
preferable when parametric or distributional assumptions 
about the underlying populations of the data sets are argu-
able [12].
Most importantly, the RIMARC algorithm learns even 
nonlinear risk score functions of the values of a given 
feature. The ranking score functions are in a human read-
able form that can be easily interpreted by domain experts. 
The feature weights learned help the experts to determine 
how they affect the ranking. In this sense, the output of 
RIMARC is inherently a Decision Support System, which 
can be used to estimate the risk of a new instance given the 
model learned from the data set.
4.4  Study limitations
There are several limitations of our study, including selec-
tion of patients and retrospective collection of clinical data. 
Criteria for selection of clinical features for this study were 
chosen not systematically, but on the basis of availability 
and anticipated relationship in some direct or indirect way 
to the pathophysiology of AF. They included plain physical 
parameters, often diagnosed comorbidities in patients with 
cardiovascular disease, routinely measured hemodynamic 
parameters, and baseline drug treatment. We could not pro-
vide an independent quality control of data, relying solely 
on the information provided by the patient files. Patients 
were considered to be in chronic AF when they had symp-
toms for at least 6 months and ECG documentation of AF 
on two occasions during this period. Patients with intermit-
tent AF or patients without any symptoms may have been 
misclassified if they were in SR at the time of surgery. 
Since all patients were surgical candidates, some clinical 
features such as diabetes or treatment with β-blockers had 
low predictive values because they occur with similar fre-
quency in severely ill cardiac patients.
5  Conclusion
The machine-learning algorithm RIMARC provides a very 
useful tool for classifying patients according to their pre-
operative rhythm status (“predicting” rhythm status) with 
high accuracy from an experimental and clinical set of data. 
In a clinical setting, this approach may prove useful for 
finding hypothesis-generating associations between differ-
ent parameters.
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